Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease

References

• Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2020 Update: a Report From the American Heart Association. Circulation. 2020;141(9):e139–e596.
   PubMed Web of Science ®Google Scholar
• Khera R, Valero-Elizondo J, Okunrintemi V, et al. Association of Out-of-Pocket Annual Health Expenditures With Financial Hardship in Low-Income Adults With Atherosclerotic Cardiovascular Disease in the United States. JAMA Cardiol. 2018;3(8):729–738.
   PubMed Web of Science ®Google Scholar
• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):1376–1414.
   PubMed Web of Science ®Google Scholar
• Global Burden of Cardiovascular Diseases Collaboration, Roth GA, Johnson CO, et al. The Burden of Cardiovascular Diseases Among US States, 1990–2016. JAMA Cardiol. 2018;3(5):375–389. doi:10.1001/jamacardio.2018.0385
   Google Scholar
• Wilmot KA, O’flaherty M, Capewell S, et al. Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011 Evidence for Stagnation in Young Adults, Especially Women. Circulation. 2015;132(11):997–1002.
   PubMed Web of Science ®Google Scholar
• Guo X, Li Z, Vittinghoff E, et al. Trends in rate of acute myocardial infarction among patients aged <30 years. Nat Rev Cardiol. 2018;15(2):119.
   PubMed Web of Science ®Google Scholar
• Izadnegahdar M, Singer J, Lee MK, et al. Do younger women fare worse? Sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years. J Womens Health (Larchmt). 2014;23(1):10–17.
   PubMed Web of Science ®Google Scholar
• O’flaherty M, Ford E, Allender S, et al. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart. 2008;94(2):178–181.
   PubMed Web of Science ®Google Scholar
• O’flaherty M, Allender S, Taylor R, et al. The decline in coronary heart disease mortality is slowing in young adults (Australia 1976–2006): a time trend analysis. Int J Cardiol. 2012;158(2):193–198.
   PubMed Web of Science ®Google Scholar
• Krittanawong C, Liu Y, Mahtta D, et al. Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort. Int J Cardiol Heart Vasc. 2020;30100634.
   Google Scholar
• Mahtta D, Khalid U, Misra A, et al. Premature Atherosclerotic Cardiovascular Disease: what Have We Learned Recently. Curr Atheroscler Rep. 2020;22(9):44.
   PubMed Web of Science ®Google Scholar
• Vikulova DN, Grubisic M, Zhao Y, et al. Premature Atherosclerotic Cardiovascular Disease: trends in Incidence, Risk Factors, and Sex‐Related Differences, 2000 to 2016. J Am Heart Assoc. 2019;8(14):e012178.
   PubMed Web of Science ®Google Scholar
• Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2018;15(4):230–240.
   PubMed Web of Science ®Google Scholar
• Khan SS, Ning H, Wilkins JT, et al. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018;3(4):280–287.
   PubMed Web of Science ®Google Scholar
• Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40(4):1195–1203.
   PubMed Web of Science ®Google Scholar
• Ge JJ, Xing YQ, Chen HX, et al. Analysis of young ischemic stroke patients in northeast China. Ann Transl Med. 2020;8(1):3.
   PubMed Web of Science ®Google Scholar
• Garshick MS, Vaidean GD, Vani A, et al. Cardiovascular Risk Factor Control and Lifestyle Factors in Young to Middle-Aged Adults with Newly Diagnosed Obstructive Coronary Artery Disease. Cardiology. 2019;142(2):83–90.
   PubMed Web of Science ®Google Scholar
• Ogden CL, Carroll MD, Fryar CD, et al. Prevalence of Obesity Among Adults and Youth: United States, 2011–2014. NCHS Data Brief. 2015;219:1–8.
   PubMedGoogle Scholar
• Ncd RFCNCD-R. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–1396.
   PubMed Web of Science ®Google Scholar
• Pandey A, Salahuddin U, Garg S, et al. Continuous Dose-Response Association Between Sedentary Time and Risk for Cardiovascular Disease: a Meta-analysis. JAMA Cardiol. 2016;1(5):575–583.
   PubMed Web of Science ®Google Scholar
• Lahtinen M, Toukola T, Junttila MJ, et al. Effect of Changes in Physical Activity on Risk for Cardiac Death in Patients With Coronary Artery Disease. Am J Cardiol. 2018;121(2):143–148.
   PubMed Web of Science ®Google Scholar
• Von Sarnowski B, Putaala J, Grittner U, et al. Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study. Stroke. 2013;44(1):119–125.
   PubMed Web of Science ®Google Scholar
• Prevention CFDCA. Trends in Meeting the 2008 Physical Activity Guidelines, 2008–2018. (2020).
   Google Scholar
• Raitakari OT, Taimela S, Porkka KV, et al. Associations between physical activity and risk factors for coronary heart disease: the Cardiovascular Risk in Young Finns Study. Med Sci Sports Exerc. 1997;29(8):1055–1061.
   PubMed Web of Science ®Google Scholar
• Salin K, Kankaanpää A, Hirvensalo M, et al. Smoking and Physical Activity Trajectories from Childhood to Midlife. Int J Environ Res Public Health. 2019;16:6.
   Web of Science ®Google Scholar
• Yang WX, Yang Z, Wu YJ, et al. Factors associated with coronary artery disease in young population (age ≤ 40): analysis with 217 cases. Chin Med Sci J. 2014;29(1):38–42.
   PubMedGoogle Scholar
• Lane JS, Vittinghoff E, Lane KT, et al. Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999–2002. J Vasc Surg. 2006;44(2):319–324.
   PubMed Web of Science ®Google Scholar
• Spengos K, Vemmos K. Risk factors, etiology, and outcome of first-ever ischemic stroke in young adults aged 15 to 45 - the Athens young stroke registry. Eur J Neurol. 2010;17(11):1358–1364.
   PubMed Web of Science ®Google Scholar
• Moskowitz WB, Schwartz PF, Schieken RM. Childhood passive smoking, race, and coronary artery disease risk: the MCV Twin Study. Medical College of Virginia. Arch Pediatr Adolesc Med. 1999;153(5):446–453.
   PubMedGoogle Scholar
• Bhatnagar A, Whitsel LP, Blaha MJ, et al. New and Emerging Tobacco Products and the Nicotine Endgame: the Role of Robust Regulation and Comprehensive Tobacco Control and Prevention: a Presidential Advisory From the American Heart Association. Circulation. 2019;139(19):e937–e958.
   PubMed Web of Science ®Google Scholar
• Gbd RFC. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–1994.
   PubMed Web of Science ®Google Scholar
• Abdullah SM, Defina LF, Leonard D, et al. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease. Circulation. 2018;138(21):2315–2325.
   PubMed Web of Science ®Google Scholar
• Maillet A, Desormais I, Rivière AB, et al. Peripheral Atheromatous Arterial Disease in the Young: risk Factors, Clinical Features, and Prognosis From the COPART Cohort. Angiology. 2017;68(10):893–898.
   PubMed Web of Science ®Google Scholar
• Ji R, Schwamm LH, Pervez MA, et al. Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol. 2013;70(1):51–57.
   PubMed Web of Science ®Google Scholar
• Navar-Boggan AM, Peterson ED, D’agostino RB, et al. Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation. 2015;131(5):451–458.
   PubMed Web of Science ®Google Scholar
• Perak AM, Ning H, Kit BK, et al. Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999–2016. JAMA. 2019;321(19):1895–1905.
   PubMed Web of Science ®Google Scholar
• De Ferranti SD, Rodday AM, Parsons SK, et al. Cholesterol Screening and Treatment Practices and Preferences: a Survey of United States Pediatricians. J Pediatr. 2017;18599–105:e2.
   Google Scholar
• Otaki Y, Gransar H, Cheng VY, et al. Gender differences in the prevalence, severity, and composition of coronary artery disease in the young: a study of 1635 individuals undergoing coronary CT angiography from the prospective, multinational confirm registry. Eur Heart J Cardiovasc Imaging. 2015;16(5):490–499.
   PubMed Web of Science ®Google Scholar
• Schneider S, Kornejeva A, Vibo R, et al. Risk Factors and Etiology of Young Ischemic Stroke Patients in Estonia. Stroke Res Treat. 2017;20178075697.
   Web of Science ®Google Scholar
• George MG, Tong X, Bowman BA. Prevalence of Cardiovascular Risk Factors and Strokes in Younger Adults. JAMA Neurol. 2017;74(6):695–703.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–613.
   PubMed Web of Science ®Google Scholar
• Krittanawong C, Kumar A, Wang Z, et al. Coronary artery disease in the young in the US population-based cohort. Am J Cardiovasc Dis. 2020;10(3):189–194.
   PubMed Web of Science ®Google Scholar
• Beckowski M, Gierlotka M, Gąsior M, et al. Risk factors predisposing to acute coronary syndromes in young women ≤45 years of age. Int J Cardiol. 2018;264165–264169.
   Google Scholar
• Davis M, Diamond J, Montgomery D, et al. Acute coronary syndrome in young women under 55 years of age: clinical characteristics, treatment, and outcomes. Clin Res Cardiol. 2015;104(8):648–655.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778–1786.
   PubMed Web of Science ®Google Scholar
• Liu LL, Lawrence JM, Davis C, et al. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes. 2010;11(1):4–11.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Nam BH, D’agostino RB, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291(18):2204–2211.
   PubMed Web of Science ®Google Scholar
• Parikh NI, Hwang SJ, Larson MG, et al. Parental occurrence of premature cardiovascular disease predicts increased coronary artery and abdominal aortic calcification in the Framingham Offspring and Third Generation cohorts. Circulation. 2007;116(13):1473–1481.
   PubMed Web of Science ®Google Scholar
• Ranthe MF, Carstensen L, Øyen N, et al. Family history of premature death and risk of early onset cardiovascular disease. J Am Coll Cardiol. 2012;60(9):814–821.
   PubMed Web of Science ®Google Scholar
• Bello-Chavolla OY, Kuri-García A, Ríos-Ríos M, et al. Familial Combined Hyperlipidemia: current Knowledge, Perspectives, and Controversies. Rev Invest Clin. 2018;70(5):224–236.
   PubMedGoogle Scholar
• Singh A, Gupta A, Collins BL, et al. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2019;73(19):2439–2450.
   PubMed Web of Science ®Google Scholar
• Mcpherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316(5830):1488–1491.
   PubMed Web of Science ®Google Scholar
• Dandona S, Stewart AF, Chen L, et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol. 2010;56(6):479–486.
   PubMed Web of Science ®Google Scholar
• Smith JG, Melander O, Lövkvist H, et al. Common genetic variants on chromosome 9p21 confers risk of ischemic stroke: a large-scale genetic association study. Circ Cardiovasc Genet. 2009;2159–2164.
   Google Scholar
• Palomaki GE, Melillo S, Bradley LA. Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA. 2010;303(7):648–656.
   PubMed Web of Science ®Google Scholar
• CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25–33. doi:10.1038/ng.2480
   Google Scholar
• Lin JS, Evans CV, Johnson E, et al. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: a Systematic Evidence Report for the U.S. Preventive Services Task Force. (2018).
   Google Scholar
• Long A, Long B, Koyfman A. Non-traditional risk factors for atherosclerotic disease: a review for emergency physicians. Am J Emerg Med. 2018;36(3):494–497.
   PubMed Web of Science ®Google Scholar
• Friedman HS. Cardiovascular effects of alcohol with particular reference to the heart. Alcohol. 1984;1(4):333–339.
   PubMedGoogle Scholar
• Mahtta D, Ahmed ST, Shah NR, et al. Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: findings From the Veterans Affairs National Database. Diabetes Care. 2020;43(5):e58–e60.
   PubMed Web of Science ®Google Scholar
• Lai S, Lima JA, Lai H, et al. Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Arch Intern Med. 2005;165(6):690–695.
   PubMed Web of Science ®Google Scholar
• Callaghan RC, Halliday M, Gatley J, et al. Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: a retrospective cohort study. Drug Alcohol Depend. 2018;188259–188265.
   Web of Science ®Google Scholar
• Westover AN, Mcbride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry. 2007;64(4):495–502.
   PubMed Web of Science ®Google Scholar
• Kolodgie FD, Virmani R, Cornhill JF, et al. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol. 1991;17(7):1553–1560.
   PubMed Web of Science ®Google Scholar
• Mechoulam R, Gaoni Y. The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Lett. 1967;8(12):1109–1111.
   Google Scholar
• Singla S, Sachdeva R, Mehta JL. Cannabinoids and atherosclerotic coronary heart disease. Clin Cardiol. 2012;35(6):329–335.
   PubMed Web of Science ®Google Scholar
• Burt JR, Agha AM, Yacoub B, et al. Marijuana use and coronary artery disease in young adults. Plos One. 2020;15(1):e0228326.
   PubMed Web of Science ®Google Scholar
• Desbois AC, Cacoub P. Cannabis-associated arterial disease. Ann Vasc Surg. 2013.
   PubMed Web of Science ®Google Scholar
• Parekh T, Pemmasani S, Desai R. Marijuana Use Among Young Adults (18–44 Years of Age) and Risk of Stroke: a Behavioral Risk Factor Surveillance System Survey Analysis. Stroke. 2020.
   Web of Science ®Google Scholar
• Defilippis EM, Bajaj NS, Singh A, et al. Marijuana Use in Patients With Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;75(3):320–332.
   PubMed Web of Science ®Google Scholar
• Bernson-Leung ME, Leung LY, Kumar S. Synthetic cannabis and acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(5):1239–1241.
   PubMed Web of Science ®Google Scholar
• Freeman MJ, Rose DZ, Myers MA, et al. Ischemic stroke after use of the synthetic marijuana spice. Neurology. 2013;81(24):2090–2093.
   PubMed Web of Science ®Google Scholar
• Baggish AL, Weiner RB, Kanayama G, et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. 2017;135(21):1991–2002.
   PubMed Web of Science ®Google Scholar
• Melhem AJ, Araújo AC, Figueiredo FNS, et al. Acute Myocardial Infarction in a Young Bodybuilder: a Case Report and Review of the Literature. Am J Case Rep. 2020;21e924796.
   Web of Science ®Google Scholar
• Christou GA, Christou KA, Nikas DN, et al. Acute myocardial infarction in a young bodybuilder taking anabolic androgenic steroids: a case report and critical review of the literature. Eur J Prev Cardiol. 2016;23(16):1785–1796.
   PubMed Web of Science ®Google Scholar
• Jain V, Goel G. Acute myocardial infarction in young newbie bodybuilder using multiple steroid and protein supplements. J Cardiol Cases. 2020;21(4):134–136.
   PubMedGoogle Scholar
• Souza FRD, Santos MRD, Porello RA. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users. Atherosclerosis. 2019.
   PubMed Web of Science ®Google Scholar
• Vorona E, Nieschlag E. Adverse effects of doping with anabolic androgenic steroids in competitive athletics, recreational sports and bodybuilding. Minerva Endocrinol. 2018;43(4):476.
   PubMed Web of Science ®Google Scholar
• Lau DH, Stiles MK, John B, et al. Atrial fibrillation and anabolic steroid abuse. Int J Cardiol. 2007;117(2):e86–7.
   PubMedGoogle Scholar
• Malarkey WB, Strauss RH, Leizman DJ, et al. Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids. Am J Obstet Gynecol. 1991;165(5 Pt 1):1385–1390.
   PubMed Web of Science ®Google Scholar
• Cocchetti C, Ristori J, Romani A, et al. Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. J Clin Med. 2020;9:6.
   Web of Science ®Google Scholar
• Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003;33(4):506–512.
   PubMed Web of Science ®Google Scholar
• Chow FC, Regan S, Zanni MV, et al. Elevated ischemic stroke risk among women living with HIV infection. AIDS. 2018;32(1):59–67.
   PubMed Web of Science ®Google Scholar
• Calvo-Sanchez M, Perelló R, Pérez I, et al. Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies. HIV Med. 2013;14(1):40–48.
   PubMed Web of Science ®Google Scholar
• Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335–344.
   PubMed Web of Science ®Google Scholar
• Losina E, Hyle EP, Borre ED, et al. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2017;65(8):1266–1271.
   PubMed Web of Science ®Google Scholar
• Sinha A, Feinstein MJ. Coronary Artery Disease Manifestations in HIV: what, How, and Why. Can J Cardiol. 2019;35(3):270–279.
   PubMed Web of Science ®Google Scholar
• Lambert CT, Sandesara PB, Hirsh B, et al. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review. HIV Med. 2016;17(6):411–424.
   PubMed Web of Science ®Google Scholar
• Currier JS, Lundgren JD, Carr A, et al. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008;118(2):e29–35.
   PubMedGoogle Scholar
• Strategies FMOATSMARTSG, El-Sadr WM, Lundgren J, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355(22):2283–2296
   PubMed Web of Science ®Google Scholar
• Silverberg MJ, Leyden WA, Xu L, et al. Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr. 2014;65(2):160–166.
   PubMed Web of Science ®Google Scholar
• Triant VA, Lee H, Hadigan C, et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endrocrinol & Metab. 2007;92(7):2506–2512.
   PubMed Web of Science ®Google Scholar
• Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015;36(8):482–495.
   PubMed Web of Science ®Google Scholar
• Mahtta D, Gupta A, Ramsey DJ, et al. Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: an Analysis From the VITAL Registry. Am J Med. 2020;133(12):1424–1432.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107(9):1303–1307.
   PubMed Web of Science ®Google Scholar
• Kwon HS, Kim YS, Lee JM, et al. Causes, Risk Factors, and Clinical Outcomes of Stroke in Korean Young Adults: systemic Lupus Erythematosus is Associated with Unfavorable Outcomes. J Clin Neurol. 2020;16(4):605–611.
   PubMed Web of Science ®Google Scholar
• Krishnan E, Pandya BJ, Chung L, et al. Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study. Arthritis Res Ther. 2011;13:2.
   Web of Science ®Google Scholar
• Lv S, Liu W, Zhou Y, et al. Hyperuricemia and severity of coronary artery disease: an observational study in adults 35 years of age and younger with acute coronary syndrome. Cardiol J. 2019;26(3):275–282.
   PubMed Web of Science ®Google Scholar
• Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019;381(26):2497–2505.
   PubMed Web of Science ®Google Scholar
• Agarwala A, Michos ED, Samad Z, et al. The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk. Circulation. 2020;141(7):592–599.
   PubMed Web of Science ®Google Scholar
• Honigberg MC, Zekavat SM, Aragam K, et al. Long-term cardiovascular risk in women with hypertension during pregnancy. J Am Coll Cardiol. 2019;74(22):2743–2754.
   PubMed Web of Science ®Google Scholar
• Wallis AB, Saftlas AF, Hsia J, et al. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am J Hypertens. 2008;21(5):521–526.
   PubMed Web of Science ®Google Scholar
• Arnaout R, Nah G, Marcus G, et al. Pregnancy complications and premature cardiovascular events among 1.6 million California pregnancies. Open Heart. 2019;6:1.
   Web of Science ®Google Scholar
• Grandi SM, Filion KB, Yoon S, et al. Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications. Circulation. 2019;139(8):1069–1079.
   PubMed Web of Science ®Google Scholar
• Ray JG, Vermeulen MJ, Schull MJ, et al. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366(9499):1797–1803.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–1594.
   PubMed Web of Science ®Google Scholar
• Rana S, Lemoine E, Granger JP, et al. Preeclampsia: pathophysiology, Challenges, and Perspectives. Circ Res. 2019;124(7):1094–1112.
   PubMed Web of Science ®Google Scholar
• Gbd IBDC. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100(2):350–358.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006;101(7):1559–1568.
   PubMed Web of Science ®Google Scholar
• Feng W, Chen G, Cai D, et al. Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: an Updated Meta-Analysis of Cohort Studies. J Am Heart Assoc. 2017;6:8.
   Web of Science ®Google Scholar
• Sun HH, Tian F. Inflammatory bowel disease and cardiovascular disease incidence and mortality: a meta-analysis. Eur J Prev Cardiol. 2018;25(15):1623–1631.
   PubMed Web of Science ®Google Scholar
• Kristensen SL, Ahlehoff O, Lindhardsen J, et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death–a Danish nationwide cohort study. PLoS One. 2013;8(2):e56944.
   PubMed Web of Science ®Google Scholar
• Cainzos-Achirica M, Glassner K, Zawahir HS, et al. Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease. J Am Coll Cardiol. 2020;76(24):2895–2905.
   PubMed Web of Science ®Google Scholar
• Sinh P, Cross R. Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020.
   PubMed Web of Science ®Google Scholar
• Yarur AJ, Deshpande AR, Pechman DM, et al. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011;106(4):741–747.
   PubMed Web of Science ®Google Scholar
• Afshar M, Pilote L, Dufresne L, et al. Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS). J Am Heart Assoc. 2016;5:4.
   Web of Science ®Google Scholar
• Mai CT, Isenburg JL, Canfield MA, et al. National population‐based estimates for major birth defects, 2010–2014. Birth Defects Res. 2019;111(18):1420–1435.
   PubMed Web of Science ®Google Scholar
• Brown ML, Burkhart HM, Connolly HM, et al. Coarctation of the aorta: lifelong surveillance is mandatory following surgical repair. J Am Coll Cardiol. 2013;62(11):1020–1025.
   PubMed Web of Science ®Google Scholar
• Pickard SS, Gauvreau K, Gurvitz M, et al. A National Population-based Study of Adults With Coronary Artery Disease and Coarctation of the Aorta. Am J Cardiol. 2018;122(12):2120–2124.
   PubMed Web of Science ®Google Scholar
• Brili S, Tousoulis D, Antoniades C, et al. Evidence of vascular dysfunction in young patients with successfully repaired coarctation of aorta. Atherosclerosis. 2005;182(1):97–103.
   PubMed Web of Science ®Google Scholar
• Gardiner HM, Celermajer DS, Sorensen KE, et al. Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood. Circulation. 1994;89(4):1745–1750.
   PubMed Web of Science ®Google Scholar
• Egbe AC, Rihal CS, Thomas A, et al. Coronary Artery Disease in Adults With Coarctation of Aorta: incidence, Risk Factors, and Outcomes. J Am Heart Assoc. 2019;8(12):e012056.
   PubMed Web of Science ®Google Scholar
• Abbasi SH, Kassaian SE, Sadeghian S, et al. Factors Associated with Depressive Symptoms in Young Adults with Coronary Artery Disease: tehran Heart Center’s Premature Coronary Atherosclerosis Cohort (THC-PAC) Study. Iran J Psychiatry. 2016;11(4):214–223.
   PubMedGoogle Scholar
• Abbasi SH, Kassaian SE, Sadeghian S, et al. Factors Associated with Anxiety in Premature Coronary Artery Disease Patients: THC-PAC Study. Acta Med Iran. 2016;54(4):261–269.
   PubMedGoogle Scholar
• Wentworth BA, Stein MB, Redwine LS, et al. Post-traumatic stress disorder: a fast track to premature cardiovascular disease. Cardiol Rev. 2013;21(1):16–22.
   PubMed Web of Science ®Google Scholar
• Hall MH, Brindle RC, Buysse DJ. Sleep and cardiovascular disease: emerging opportunities for psychology. Am Psychol. 2018;73(8):994–1006.
   PubMed Web of Science ®Google Scholar
• Yang Q, Cogswell ME, Flanders WD, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–1283.
   PubMed Web of Science ®Google Scholar
• Artinian NT, Fletcher GF, Mozaffarian D, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(4):406–441.
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Furie KL, Iadecola C, et al. Defining Optimal Brain Health in Adults: a Presidential Advisory From the American Heart Association/American Stroke Association. Stroke. 2017;48(10):e284–e303.
   PubMed Web of Science ®Google Scholar
• Strath SJ, Kaminsky LA, Ainsworth BE, et al. Guide to the assessment of physical activity: clinical and research applications: a scientific statement from the American Heart Association. Circulation. 2013;128(20):2259–2279.
   PubMed Web of Science ®Google Scholar
• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596–e646.
   PubMed Web of Science ®Google Scholar
• Nadir MA, Struthers AD. Family history of premature coronary heart disease and risk prediction. Heart. 2011;97(8):684.
   PubMed Web of Science ®Google Scholar
• Blankstein R, Singh A. Cholesterol guidelines: a missed opportunity for young adults; 2020.
   Google Scholar
• Akosah KO, Schaper A, Cogbill C, et al. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform. J Am Coll Cardiol. 2003;41(9):1475–1479.
   PubMed Web of Science ®Google Scholar
• Navar-Boggan AM, Peterson ED, D’agostino RB, et al. Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all. J Am Coll Cardiol. 2015;65(16):1633–1639.
   PubMed Web of Science ®Google Scholar
• Zeitouni M, Nanna MG, Sun JL, et al. Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults. J Am Coll Cardiol. 2020;76(6):653–664.
   PubMed Web of Science ®Google Scholar
• Reynolds TM, Twomey P, Wierzbicki AS. Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes. J Cardiovasc Risk. 2002;9(4):183–190.
   PubMedGoogle Scholar
• Pashkow FJ. The prudent person’s paradox. J Am Coll Cardiol. 2003;41(9):1480–1481.
   PubMed Web of Science ®Google Scholar
• Gooding HC, Ning H, Gillman MW, et al. Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Intern Med. 2017;177(9):1354–1360.
   PubMed Web of Science ®Google Scholar
• Joseph P, Yusuf S, Lee SF, et al. Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world. Heart. 2018;104(7):581–587.
   PubMed Web of Science ®Google Scholar
• Fernández-Alvira JM, Fuster V, Pocock S, et al. Predicting Subclinical Atherosclerosis in Low-Risk Individuals: ideal Cardiovascular Health Score and Fuster-BEWAT Score. J Am Coll Cardiol. 2017;70(20):2463–2473.
   PubMed Web of Science ®Google Scholar
• Patel J, Al Rifai M, Blaha MJ, et al. Coronary Artery Calcium Improves Risk Assessment in Adults With a Family History of Premature Coronary Heart Disease: results From Multiethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2015;8(6):e003186.
   PubMed Web of Science ®Google Scholar
• Juonala M, Viikari JSA, Rasanen LA, et al. Young adults with family history of coronary heart disease have increased arterial vulnerability to metabolic risk factors - The cardiovascular risk in Young Finns study. Arteriosclerosis Thrombosis and Vascular Surgery. 2006;26(6):1376–1382.
   PubMed Web of Science ®Google Scholar
• Jubran A, Zetser A, Zafrir B. Lipoprotein(a) screening in young and middle-aged patients presenting with acute coronary syndrome. Cardiol J. 2019;26(5):511–518.
   PubMed Web of Science ®Google Scholar
• Hoogeveen RC, Ballantyne CM. Residual Cardiovascular Risk at Low LDL: remnants, Lipoprotein(a), and Inflammation. Clin Chem. 2020.
   Web of Science ®Google Scholar
• Aguilar D, Sun C, Hoogeveen RC, et al. Levels and Change in Galectin-3 and Association With Cardiovascular Events: the ARIC Study. J Am Heart Assoc. 2020;9(13):e015405.
   PubMed Web of Science ®Google Scholar
• Martínez PJ, Baldán-Martín M, López JA, et al. Identification of six cardiovascular risk biomarkers in the young population: a promising tool for early prevention. Atherosclerosis. 2019;28267–28274.
   Web of Science ®Google Scholar
• Heller DJ, Coxson PG, Penko J, et al. Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke. Circulation. 2017;136(12):1087–1098.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285–e350.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet. 2006;368(9542):1155–1163.
   PubMed Web of Science ®Google Scholar
• Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1615–1622;279(20):1998.
   Google Scholar
• Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Bosch J, Dagenais G, et al. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016;374(21):2021–2031.
   PubMed Web of Science ®Google Scholar
• Virani SS, Ballantyne CM. Low-Density Lipoprotein Cholesterol: is 160 the New 190. Circulation. 2018;138(21):2326–2329.
   PubMed Web of Science ®Google Scholar
• Van Dongen MME, Aarnio K, Martinez-Majander N, et al. Use of statins after ischemic stroke in young adults and its association with long-term outcome. Stroke. 2019;50(12):3385–3392.
   PubMed Web of Science ®Google Scholar
• Rodriguez F, Maron DJ, Knowles JW, et al. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2017;2(1):47–54.
   PubMed Web of Science ®Google Scholar
• Mahtta D, Ramsey DJ, Al Rifai M, et al. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Network Open. 2020;3(8):e2011051.
   PubMed Web of Science ®Google Scholar
• Dixon DL, Sharma G, Sandesara PB, et al. Therapeutic Inertia in Cardiovascular Disease Prevention: time to Move the Bar. J Am Coll Cardiol. 2019;74(13):1728–1731.
   PubMed Web of Science ®Google Scholar
• Gupta A, Wang Y, Spertus JA, et al. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol. 2014;64(4):337–345.
   PubMed Web of Science ®Google Scholar
• Nanna MG, Wang TY, Xiang Q, et al. Sex Differences in the Use of Statins in Community Practice. Circ Cardiovasc Qual Outcomes. 2019;12(8):e005562.
   PubMed Web of Science ®Google Scholar
• Newman CB, Preiss D, Tobert JA, et al. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2019;39(2):e38–e81.
   PubMed Web of Science ®Google Scholar
• Jia X, Lee MT, Ramsey DJ, et al. Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System. Cardiovasc Drugs Ther. 2021.
   Web of Science ®Google Scholar